Awarded

Everolimus 10 mg Tabletten (Indikationen: Mammakarzinom, Neuroendokrine Tumoren, Nierenzellkarzinom) St

Original language: German

Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
Buyer
PBMG eG
Contract value
no value published
Bids received
4
Published
16 Oct 2026
Awarded
16 Oct 2026
Contract start
1 Jul 2027
Contract end
30 Jun 2029stated
Region
Hamburg

More awards from this buyer

Everolimus 10 mg Tabletten (Indikationen: Mammakarzinom, Neuroendokrine Tumoren, Nierenzellkarzinom) St — Viatris Healthcare GmbH · Adjudera